Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/05/2008
 
Trade Name:  Argatroban
 
Generic Name or Proper Name (*):  argatroban
 
Indications Studied:  Heparin-Induced Thrombocytopenia (HIT) or HIT with Thrombosis
 
Label Changes Summary:  Safety and effectiveness, including the appropriate anticoagulation goals and duration of therapy, have not been established in pediatric patients Population PK/PD analysis of sparse data in 15 seriously ill pediatric patients ages <6 months  16 years diagnosed with HIT or suspected HIT requiring an alternative to heparin anticoagulation showed clearance in pediatric patients was 50% lower compared to healthy adults and led to dose recommendations Information on dose, AEs and PK
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  Encysive
 
NNPS:  FALSE'
 
Therapeutic Category:  Hematology/Coagulation
 
-
-